Results 91 to 100 of about 23,910 (287)

Efficacy of lurasidone on anxiety symptoms in patients with schizophrenia: A pooled post hoc analysis of five randomized, placebo‐controlled trials

open access: yesPCN Reports
Aim Comorbid anxiety disorders and their symptoms are common in schizophrenia and may occur before a relapse. The aim of this post hoc analysis is to investigate the efficacy of lurasidone on comorbid anxiety symptoms in patients with schizophrenia ...
Takahiro Nemoto   +2 more
doaj   +1 more source

Assessing the Attitudes and Clinical Practices of Ohio Dentists Treating Patients with Dental Anxiety

open access: yesDentistry Journal, 2016
Dental anxiety (DA) negatively affects patients’ oral and overall health. This study explored attitudes and clinical practices of licensed Ohio general dentists who treat patients with DA.
Kristin A. Williams   +2 more
doaj   +1 more source

Analytical Approaches to Address Challenges in the Analysis of Cannabinoids in Vascular Matrices Using Mass Spectrometry

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Phytocannabinoids are bioactive metabolites derived from the Cannabis sativa plant. They have garnered attention due to their recreational uses and therapeutic potential. Although various analytical strategies have been employed for their analysis, mass spectrometry (MS) coupled to chromatographic separation is superior due to its sensitivity ...
Radwa Mahmoud   +2 more
wiley   +1 more source

Assessment of Emerging Contaminants in Treated Wastewater Through Plant-Based Biotests

open access: yesAgriculture
Given the increasing concern about the presence of emerging contaminants in wastewater and their persistence in the environment, this study aimed to assess the effects of two anxiolytic pharmaceuticals commonly used in human therapy—Tranxilium ...
Irene Tercero, Pilar Mañas
doaj   +1 more source

Somatoform disorders in the family doctor's practice [PDF]

open access: yesMedičnì Perspektivi, 2013
In the second part of the article devoted to the problem of somatoform disorders, hypochondriacal disorder, somatoform dysfunction of the autonomic nervous system and sustained somatoform pain disorder are reviewed.
Prykhodko V.Yu.   +8 more
doaj  

A Review of Geographic Tongue Journey: From Diagnosis to Therapeutic Considerations [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Geographic Tongue (GT) affects the mucous membrane of the tongue and is a non cancerous condition that causes smooth, reddish regions resemble maps.
Kaushal Mangtani   +3 more
doaj   +1 more source

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero   +12 more
wiley   +1 more source

High‐Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy

open access: yesMovement Disorders, EarlyView.
Abstract Background Multiple system atrophy (MSA) is a rare and devastating neurodegenerative disorder. Accumulating clinical and preclinical evidence suggests that diabetes and insulin resistance may adversely influence MSA pathophysiology. Objective We investigated the potential association between diabetes, impaired glucose homeostasis, and MSA ...
Marie‐Laure Arotcarena   +7 more
wiley   +1 more source

Association between bystander cardiopulmonary resuscitation and redeemed prescriptions for antidepressants and anxiolytics in out-of-hospital cardiac arrest survivors

open access: yes, 2017
AIM: This study aimed to examine rates of redeemed prescriptions of antidepressants and anxiolytics, used as markers for cerebral dysfunction in out-of-hospital cardiac arrest (OHCA) survivors, and examine the association between bystander CPR and these ...
Rikke Nørmark Mortensen   +28 more
core   +1 more source

Developing the Dopamine D3 Receptor (D3R) Antagonist, (R)‐VK4‐116, as a Non‐Opioid Medication for the Treatment of Opioid Use Disorder

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Opioid use disorder (OUD) remains a major global health challenge, and currently approved treatments (methadone, buprenorphine, and naltrexone) are all opioid receptor‐targeting drugs with limitations in access, adherence, stigma, and use in polysubstance use disorders. Because the dopamine D3 receptor (D3R) is enriched in limbic brain regions
Chia‐Kuei Wu   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy